Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
– New Composition of Matter Intellectual Property (“IP”) Filing Centered on First-in-Class, Fully Synthetically Manufactured